Hoàng Thị, H. and Phạm Cẩm, P. 2025. THE RESULTS OF GEFTINIB AS THE FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS HARBORING EGFR MUTATIONS. Vietnam Medical Journal. 551, 3 (Jul. 2025). DOI:https://doi.org/10.51298/vmj.v551i3.14682.